Expert Series: Hope on the Horizon: The Vital Role of Patients in Clinical Research

March 15, 2025 • 01:17:36
Expert Series: Hope on the Horizon: The Vital Role of Patients in Clinical Research
MitoAction Expert Series
Expert Series: Hope on the Horizon: The Vital Role of Patients in Clinical Research

Mar 15 2025 | 01:17:36

/

Show Notes

There is unprecedented momentum in the mitochondrial disease clinical trial landscape, and the patient community plays a vital role in ensuring these trials have the potential to lead to new and effective treatments. This expert series aims to demystify clinical trial participation and answer your most pressing questions.  Dr. Amy Goldstein, Clinical Director of the Mitochondrial Medicine Frontier Program will discuss what to expect if you participate in clinical trials, and highlight their importance in the drug approval process, and Chad Glasser, Sr. Director of Clinical Research at Tisento Therapeutics, will discuss the actively recruiting PRIZM MELAS study.

Other Episodes

Episode

March 08, 2025 • 01:22:27
Episode Cover

Expert Series: Ins and Outs of the Mito Cocktail: Pat 1 of 2

In the, “Ins and Outs of the Mito Cocktail: Part 1 of 2,” Dr. Toufas will explore how our bodies digest and absorb nutrients...

Listen

Episode 0

July 03, 2020 • NaN
Episode Cover

How Enteric Microbiome Mitochondrial Function - Dr. Richard Frye - 9/22/17

Richard Frye, MD, PhD, FAAP, FAAN, CPI, discusses how  Enteric (gut) Microbiome Modulates Mitochondrial Function. Talking points include: The enteric (gut) microbiome has an...

Listen

Episode

January 28, 2026 • 00:39:28
Episode Cover

Understanding TK2d and the KYGEVVI Approval

Join us for an informative webinar exploring KYGEVVI™ (doxecitine and doxribtimine), the first FDA-approved treatment for thymidine kinase 2 deficiency (TK2d) in adults and...

Listen